Antón Álvarez

687 total citations
20 papers, 506 citations indexed

About

Antón Álvarez is a scholar working on Neurology, Pharmacology and Molecular Biology. According to data from OpenAlex, Antón Álvarez has authored 20 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 7 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in Antón Álvarez's work include Neurological Disorders and Treatments (9 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Neurological Disease Mechanisms and Treatments (3 papers). Antón Álvarez is often cited by papers focused on Neurological Disorders and Treatments (9 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Neurological Disease Mechanisms and Treatments (3 papers). Antón Álvarez collaborates with scholars based in Spain, Russia and Romania. Antón Álvarez's co-authors include Ramón Cacabelos, Manuel Aleixandre, Manuel García-Fantini, Valter Lombardi, Gavrilova Si, Herbert Moessler, et al., Carlos Sánchez‐Linares, Eliezer Masliah and L. Fernández‐Novoa and has published in prestigious journals such as Fertility and Sterility, Neurobiology of Aging and Journal of Alzheimer s Disease.

In The Last Decade

Antón Álvarez

20 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antón Álvarez Spain 9 201 184 127 86 78 20 506
Lingfei Ruan China 7 218 1.1× 185 1.0× 156 1.2× 56 0.7× 91 1.2× 9 481
Natalia M. Lyra e Silva Canada 8 346 1.7× 155 0.8× 198 1.6× 81 0.9× 116 1.5× 9 677
Ivica Granic Netherlands 9 194 1.0× 130 0.7× 174 1.4× 89 1.0× 126 1.6× 12 496
S.H. MacGowan United Kingdom 12 427 2.1× 207 1.1× 259 2.0× 149 1.7× 184 2.4× 13 783
Jiazhao Xie China 13 304 1.5× 119 0.6× 220 1.7× 79 0.9× 85 1.1× 20 610
Tetsade Piermartiri Brazil 13 168 0.8× 110 0.6× 210 1.7× 53 0.6× 192 2.5× 19 576
Rebekka Wittrahm Finland 6 239 1.2× 132 0.7× 177 1.4× 77 0.9× 57 0.7× 7 461
Diana Thyssen United States 5 291 1.4× 92 0.5× 102 0.8× 94 1.1× 72 0.9× 5 379
Agnieszka Falinska United Kingdom 6 215 1.1× 121 0.7× 113 0.9× 69 0.8× 95 1.2× 9 367
Michael Hüell Germany 10 165 0.8× 240 1.3× 96 0.8× 80 0.9× 48 0.6× 14 506

Countries citing papers authored by Antón Álvarez

Since Specialization
Citations

This map shows the geographic impact of Antón Álvarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antón Álvarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antón Álvarez more than expected).

Fields of papers citing papers by Antón Álvarez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antón Álvarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antón Álvarez. The network helps show where Antón Álvarez may publish in the future.

Co-authorship network of co-authors of Antón Álvarez

This figure shows the co-authorship network connecting the top 25 collaborators of Antón Álvarez. A scholar is included among the top collaborators of Antón Álvarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antón Álvarez. Antón Álvarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rejdak, Konrad, Halina Sienkiewicz‐Jarosz, Przemysław Bieńkowski, & Antón Álvarez. (2023). Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin. Medicinal Research Reviews. 43(5). 1668–1700. 21 indexed citations
2.
Si, Gavrilova & Antón Álvarez. (2020). Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use. Medicinal Research Reviews. 41(5). 2775–2803. 43 indexed citations
3.
4.
5.
Mureșanu, Dafin F., Antón Álvarez, V. Hömberg, et al.. (2018). VaD - An Integrated Framework for Cognitive Rehabilitation. CNS & Neurological Disorders - Drug Targets. 17(1). 22–33. 7 indexed citations
6.
Álvarez, Antón, Manuel Aleixandre, Carlos Sánchez‐Linares, et al.. (2014). P3‐396: CEREBROLYSIN AND COMBINATION THERAPY ENHANCE SERUM BDNF IN AD PATIENTS. Alzheimer s & Dementia. 10(4S_Part_21). 2 indexed citations
7.
Álvarez, Antón, Manuel Aleixandre, Carlos Sánchez‐Linares, Eliezer Masliah, & Herbert Moessler. (2014). Apathy and APOE4 are associated with Reduced BDNF Levels in Alzheimer's Disease. Journal of Alzheimer s Disease. 42(4). 1347–1355. 51 indexed citations
8.
Cacabelos, Ramón, L. Fernández‐Novoa, Adam R. McKay, et al.. (2010). Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants. Pharmaceuticals. 3(10). 3040–3100. 31 indexed citations
9.
Álvarez, Antón, et al.. (2009). P1‐272: Opposite effects of cerebrolysin on serum TNF‐alpha and IGF‐I levels in Alzheimer's disease. Alzheimer s & Dementia. 5(4S_Part_9). 1 indexed citations
10.
11.
Álvarez, Antón, Ramón Cacabelos, Manuel Aleixandre, et al.. (2009). P1‐244: Combined treatment with cerebrolysin and donepezil in mild to moderate alzheimer's disease: Results of a double‐blind, randomized clinical trial. Alzheimer s & Dementia. 5(4S_Part_8). 1 indexed citations
12.
Álvarez, Antón, Carolina Sampedro, Ramón Cacabelos, et al.. (2008). P2‐385: Cerebrolysin reduces TNF‐alpha and soluble TNF receptor‐I levels in the serum of Alzheimer's disease patients. Alzheimer s & Dementia. 4(4S_Part_15). 2 indexed citations
13.
Álvarez, Antón, et al.. (2006). Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiology of Aging. 28(4). 533–536. 233 indexed citations
14.
15.
Cacabelos, Ramón, et al.. (2000). A pharmacogenomic approach to Alzheimer’s disease. Acta Neurologica Scandinavica. 102. 12–19. 33 indexed citations
16.
Cacabelos, Ramón, Antón Álvarez, Valter Lombardi, & et al.. (2000). Pharmacological treatment of Alzheimer disease: From psychotropicdrugs and cholinesterase inhibitors to pharmacogenomics. Drugs of today. 36(7). 415–415. 46 indexed citations
17.
Álvarez, Antón, et al.. (2000). Dose-dependent effects of anapsos in senile dementia patients: A double-blind, randomized, placebo controlled study. Neurobiology of Aging. 21. 218–218. 2 indexed citations
18.
Miguel-Hidalgo, José Javier, et al.. (1998). Neuroprotective role of S12024 against neurodegeneration in the rat dentate gyrus. European Neuropsychopharmacology. 8(3). 203–208. 6 indexed citations
19.
Álvarez, Antón, et al.. (1997). Anapsos: Neuroimmunotrophic Treatment in Alzheimer Disease and Neurodegenerative Disorders. CNS Drug Reviews. 3(2). 181–206. 9 indexed citations
20.
Álvarez, Antón. (1970). “Publicidad y salud”: un manual práctico para conocer los cambios. Dialnet (Universidad de la Rioja). 4. 109–114. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lingfei Ruan Breakdown of academic impact, for papers by Natalia M. Lyra e Silva Breakdown of academic impact, for papers by Ivica Granic Breakdown of academic impact, for papers by S.H. MacGowan Breakdown of academic impact, for papers by Jiazhao Xie Breakdown of academic impact, for papers by Tetsade Piermartiri Breakdown of academic impact, for papers by Rebekka Wittrahm Breakdown of academic impact, for papers by Diana Thyssen Breakdown of academic impact, for papers by Agnieszka Falinska Breakdown of academic impact, for papers by Michael Hüell
Rankless by CCL
2026